AIM ImmunoTech to commence study of intranasal Covid-19 therapy
AIM ImmunoTech is set to commence the Phase I clinical study of its Ampligen drug...
InteRNA Technologies begins dosing in solid tumour drug trial
InteRNA Technologies has dosed the first patient in the first cohort of its first-in-human Phase...
AstraZeneca’s Farxiga prolongs survival in chronic kidney disease trial
AstraZeneca has reported positive data from a subgroup analysis from Phase III DAPA-CKD trial of...
Micreos starts trial of first endolysin-drug for atopic dermatitis
Dutch biotech company Micreos Human Health has initiated a Phase I/IIa clinical trial to evaluate...
Intravacc reports positive data from Phase I trial of RSV vaccine
Dutch vaccines developer Intravacc has reported positive results from the Phase I clinical trial of...
MIT Optimal Sourcing Solutions
MIT Optimal Sourcing Solutions is a dedicated supplier of comparator drugs, specialised in European Union...
InflaRx starts dosing Covid-19 patients in Europe
German biopharmaceutical firm InflaRx has enrolled and dosed the first patient in a clinical study...
ProQR doses first patient in Aurora trial of retinal disease therapy
ProQR Therapeutics has dosed the first patient in a Phase I/II Aurora clinical trial to...
Gilead and Galapagos report data from filgotinib trials in RA
US antiviral drugmaker Gilead Sciences and Belgo-Dutch biotech Galapagos have announced week 52 data from...
ProQR to study new drug candidate for retinitis pigmentosa
ProQR Therapeutics has announced plans to conduct a Phase I/II clinical trial to evaluate QR-1123...